{"transactions":[{"id":4391,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":10043,"kind":"person","name":"TYNDALL JOSEPH A.","position":1,"cik":"0001955281","reported_name":"TYNDALL JOSEPH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-04T20:08:06.000Z","date":"2026-09-02","kind":"sale","planned":true,"acquired":false,"shares":3500,"price":49.697,"value":173939.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on the this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on June 3, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $48.01 to $51.46 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":10650,"source":{"system":"sec-edgar","filing":"0000805928-26-000101","document":"wk-form4_1788552483.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1955281/000080592826000101/wk-form4_1788552483.xml","form_type":"4"}},{"id":689966,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24363,"kind":"person","name":"Began Marc A","position":1,"cik":"0001821352","reported_name":"Began Marc A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-08-12T20:13:23.000Z","date":"2026-08-10","kind":"exercise","planned":true,"acquired":false,"shares":67500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All shares of Axogen Inc. common stock underlying the stock option grant will be fully vested on March 1, 2027 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate stock options vest on March 1, 2025 (24 months from the grant date) and an additional 12.5% of the aggregate stock options vest each 6 months thereafter."}],"balance_after":22500,"derivative":{"exercise_price":8.16,"expiration_date":"2033-03-01","underlying":"Common Stock","underlying_shares":67500},"source":{"system":"sec-edgar","filing":"0000805928-26-000099","document":"wk-form4_1786565598.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000099/wk-form4_1786565598.xml","form_type":"4"}},{"id":689965,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24363,"kind":"person","name":"Began Marc A","position":1,"cik":"0001821352","reported_name":"Began Marc A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock","published_at":"2026-08-12T20:13:23.000Z","date":"2026-08-10","kind":"sale","planned":true,"acquired":false,"shares":67500,"price":47.345,"value":3195787.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $47.16 to $47.72 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":50135,"source":{"system":"sec-edgar","filing":"0000805928-26-000099","document":"wk-form4_1786565598.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000099/wk-form4_1786565598.xml","form_type":"4"}},{"id":689964,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24363,"kind":"person","name":"Began Marc A","position":1,"cik":"0001821352","reported_name":"Began Marc A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock","published_at":"2026-08-12T20:13:23.000Z","date":"2026-08-10","kind":"exercise","planned":true,"acquired":true,"shares":67500,"price":8.16,"value":550800.0,"ownership":{"direct":true},"balance_after":117635,"source":{"system":"sec-edgar","filing":"0000805928-26-000099","document":"wk-form4_1786565598.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000099/wk-form4_1786565598.xml","form_type":"4"}},{"id":689962,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to purchase)","published_at":"2026-08-12T20:12:49.000Z","date":"2026-08-11","kind":"exercise","planned":true,"acquired":false,"shares":13353,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All shares of Axogen, Inc. common stock underlying the board of director's stock option were fully vested on May 14, 2018."}],"balance_after":0,"derivative":{"exercise_price":14.85,"expiration_date":"2027-06-01","underlying":"Common Stock","underlying_shares":13353},"source":{"system":"sec-edgar","filing":"0000805928-26-000098","document":"wk-form4_1786565567.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000098/wk-form4_1786565567.xml","form_type":"4"}},{"id":689961,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-12T20:12:49.000Z","date":"2026-08-11","kind":"sale","planned":true,"acquired":false,"shares":13353,"price":48.423,"value":646592.319,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on the this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on May 12, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $47.82 to $49.02 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":107976,"source":{"system":"sec-edgar","filing":"0000805928-26-000098","document":"wk-form4_1786565567.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000098/wk-form4_1786565567.xml","form_type":"4"}},{"id":689960,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-12T20:12:49.000Z","date":"2026-08-11","kind":"exercise","planned":true,"acquired":true,"shares":13353,"price":14.85,"value":198292.05,"ownership":{"direct":true},"balance_after":121329,"source":{"system":"sec-edgar","filing":"0000805928-26-000098","document":"wk-form4_1786565567.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000098/wk-form4_1786565567.xml","form_type":"4"}},{"id":691438,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24844,"kind":"person","name":"Weiler Kathy Johnson","position":1,"cik":"0001979466","reported_name":"Weiler Kathy Johnson","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-11T20:15:35.000Z","date":"2026-08-07","kind":"sale","planned":true,"acquired":false,"shares":14150,"price":45.298,"value":640966.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 8, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $44.43 to $46.47 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000805928-26-000096","document":"wk-form4_1786479331.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000096/wk-form4_1786479331.xml","form_type":"4"}},{"id":725991,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-26T20:53:14.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":4392,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $185,000 valuation as of the grant date and vests on June 24, 2027, the one-year anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $185,000 valuation as of the grant date and vests on June 24, 2027, the one-year anniversary of the grant date."}],"balance_after":4392,"derivative":{"underlying":"Common Stock","underlying_shares":4392},"source":{"system":"sec-edgar","filing":"0001682069-26-000002","document":"wk-form4_1782507192.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000168206926000002/wk-form4_1782507192.xml","form_type":"4"}},{"id":725989,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":13228,"kind":"person","name":"JOHNSON JOHN","position":1,"cik":"0001410781","reported_name":"JOHNSON JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-26T20:53:07.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":4392,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $185,000 valuation as of the grant date and vests on June 24, 2027, the one-year anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $185,000 valuation as of the grant date and vests on June 24, 2027, the one-year anniversary of the grant date."}],"balance_after":4392,"derivative":{"underlying":"Common Stock","underlying_shares":4392},"source":{"system":"sec-edgar","filing":"0001410781-26-000008","document":"wk-form4_1782507185.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000141078126000008/wk-form4_1782507185.xml","form_type":"4"}},{"id":725988,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35287,"kind":"person","name":"Levine Alan M","position":1,"cik":"0001766833","reported_name":"Levine Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-26T20:52:58.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":4392,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $185,000 valuation as of the grant date and vests on June 24, 2027, the one-year anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $185,000 valuation as of the grant date and vests on June 24, 2027, the one-year anniversary of the grant date."}],"balance_after":4392,"derivative":{"underlying":"Common Stock","underlying_shares":4392},"source":{"system":"sec-edgar","filing":"0000805928-26-000089","document":"wk-form4_1782507176.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000089/wk-form4_1782507176.xml","form_type":"4"}},{"id":725987,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-26T20:52:51.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":5579,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $235,000 valuation as of the grant date and vests on June 24, 2027, the one-year anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $235,000 valuation as of the grant date and vests on June 24, 2027, the one-year anniversary of the grant date."}],"balance_after":5579,"derivative":{"underlying":"Common Stock","underlying_shares":5579},"source":{"system":"sec-edgar","filing":"0000805928-26-000088","document":"wk-form4_1782507169.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000088/wk-form4_1782507169.xml","form_type":"4"}},{"id":725986,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":10043,"kind":"person","name":"TYNDALL JOSEPH A.","position":1,"cik":"0001955281","reported_name":"TYNDALL JOSEPH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-26T20:52:43.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":4392,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $185,000 valuation as of the grant date and vests on June 24, 2027, the one-year anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $185,000 valuation as of the grant date and vests on June 24, 2027, the one-year anniversary of the grant date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $185,000 valuation as of the grant date and vests on June 24, 2027, the one-year anniversary of the grant date."}],"balance_after":4392,"derivative":{"underlying":"Common Stock","underlying_shares":4392},"source":{"system":"sec-edgar","filing":"0000805928-26-000087","document":"wk-form4_1782507161.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000087/wk-form4_1782507161.xml","form_type":"4"}},{"id":725985,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24844,"kind":"person","name":"Weiler Kathy Johnson","position":1,"cik":"0001979466","reported_name":"Weiler Kathy Johnson","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-26T20:52:34.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":4392,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $185,000 valuation as of the grant date and vests on June 24, 2027, the one-year anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $185,000 valuation as of the grant date and vests on June 24, 2027, the one-year anniversary of the grant date."}],"balance_after":4392,"derivative":{"underlying":"Common Stock","underlying_shares":4392},"source":{"system":"sec-edgar","filing":"0000805928-26-000086","document":"wk-form4_1782507152.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000086/wk-form4_1782507152.xml","form_type":"4"}},{"id":725984,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-26T20:52:22.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":4392,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $185,000 valuation as of the grant date and vests on June 24, 2027, the one-year anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $185,000 valuation as of the grant date and vests on June 24, 2027, the one-year anniversary of the grant date."}],"balance_after":4392,"derivative":{"underlying":"Common Stock","underlying_shares":4392},"source":{"system":"sec-edgar","filing":"0001400568-26-000015","document":"wk-form4_1782507140.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000140056826000015/wk-form4_1782507140.xml","form_type":"4"}},{"id":729771,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35287,"kind":"person","name":"Levine Alan M","position":1,"cik":"0001766833","reported_name":"Levine Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-23T20:37:20.000Z","date":"2026-06-19","kind":"exercise","planned":false,"acquired":true,"shares":14150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on June 19, 2026, the one-year anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on June 19, 2026, the one-year anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":14150},"source":{"system":"sec-edgar","filing":"0000805928-26-000080","document":"wk-form4_1782247037.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000080/wk-form4_1782247037.xml","form_type":"4"}},{"id":729770,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35287,"kind":"person","name":"Levine Alan M","position":1,"cik":"0001766833","reported_name":"Levine Alan M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-23T20:37:20.000Z","date":"2026-06-19","kind":"exercise","planned":false,"acquired":true,"shares":14150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of restricted stock units that vested June 19, 2026."}],"balance_after":50893,"source":{"system":"sec-edgar","filing":"0000805928-26-000080","document":"wk-form4_1782247037.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000080/wk-form4_1782247037.xml","form_type":"4"}},{"id":729769,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24844,"kind":"person","name":"Weiler Kathy Johnson","position":1,"cik":"0001979466","reported_name":"Weiler Kathy Johnson","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-23T20:37:03.000Z","date":"2026-06-19","kind":"exercise","planned":false,"acquired":true,"shares":14150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on June 19, 2026, the one-year anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on June 19, 2026, the one-year anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":14150},"source":{"system":"sec-edgar","filing":"0000805928-26-000079","document":"wk-form4_1782247020.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000079/wk-form4_1782247020.xml","form_type":"4"}},{"id":729768,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24844,"kind":"person","name":"Weiler Kathy Johnson","position":1,"cik":"0001979466","reported_name":"Weiler Kathy Johnson","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-23T20:37:03.000Z","date":"2026-06-19","kind":"exercise","planned":false,"acquired":true,"shares":14150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of restricted stock units that vested June 19, 2026."}],"balance_after":14150,"source":{"system":"sec-edgar","filing":"0000805928-26-000079","document":"wk-form4_1782247020.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000079/wk-form4_1782247020.xml","form_type":"4"}},{"id":729767,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-23T20:36:41.000Z","date":"2026-06-19","kind":"exercise","planned":false,"acquired":true,"shares":14150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on June 19, 2026, the one-year anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on June 19, 2026, the one-year anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":14150},"source":{"system":"sec-edgar","filing":"0001400568-26-000013","document":"wk-form4_1782246998.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000140056826000013/wk-form4_1782246998.xml","form_type":"4"}},{"id":729766,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-23T20:36:41.000Z","date":"2026-06-19","kind":"exercise","planned":false,"acquired":true,"shares":14150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of restricted stock units that vested June 19, 2026."}],"balance_after":107976,"source":{"system":"sec-edgar","filing":"0001400568-26-000013","document":"wk-form4_1782246998.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000140056826000013/wk-form4_1782246998.xml","form_type":"4"}},{"id":729765,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-23T20:36:22.000Z","date":"2026-06-19","kind":"exercise","planned":false,"acquired":true,"shares":18867,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $200,000 valuation as of the grant date and vests on June 19, 2026, the one-year anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $200,000 valuation as of the grant date and vests on June 19, 2026, the one-year anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":18867},"source":{"system":"sec-edgar","filing":"0000805928-26-000078","document":"wk-form4_1782246978.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000078/wk-form4_1782246978.xml","form_type":"4"}},{"id":729764,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-23T20:36:22.000Z","date":"2026-06-19","kind":"exercise","planned":false,"acquired":true,"shares":18867,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of restricted stock units that vested June 19, 2026."}],"balance_after":32395,"source":{"system":"sec-edgar","filing":"0000805928-26-000078","document":"wk-form4_1782246978.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000078/wk-form4_1782246978.xml","form_type":"4"}},{"id":729763,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":10043,"kind":"person","name":"TYNDALL JOSEPH A.","position":1,"cik":"0001955281","reported_name":"TYNDALL JOSEPH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-23T20:36:03.000Z","date":"2026-06-19","kind":"exercise","planned":false,"acquired":true,"shares":14150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on June 19, 2026, the one-year anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on June 19, 2026, the one-year anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":14150},"source":{"system":"sec-edgar","filing":"0000805928-26-000077","document":"wk-form4_1782246960.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000077/wk-form4_1782246960.xml","form_type":"4"}},{"id":729762,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":10043,"kind":"person","name":"TYNDALL JOSEPH A.","position":1,"cik":"0001955281","reported_name":"TYNDALL JOSEPH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-23T20:36:03.000Z","date":"2026-06-19","kind":"exercise","planned":false,"acquired":true,"shares":14150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of restricted stock units that vested June 19, 2026."}],"balance_after":14150,"source":{"system":"sec-edgar","filing":"0000805928-26-000077","document":"wk-form4_1782246960.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000077/wk-form4_1782246960.xml","form_type":"4"}},{"id":729761,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":13228,"kind":"person","name":"JOHNSON JOHN","position":1,"cik":"0001410781","reported_name":"JOHNSON JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-23T20:35:45.000Z","date":"2026-06-19","kind":"exercise","planned":false,"acquired":true,"shares":14150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on June 19, 2026, the one-year anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on June 19, 2026, the one-year anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":14150},"source":{"system":"sec-edgar","filing":"0001410781-26-000006","document":"wk-form4_1782246942.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000141078126000006/wk-form4_1782246942.xml","form_type":"4"}},{"id":729760,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":13228,"kind":"person","name":"JOHNSON JOHN","position":1,"cik":"0001410781","reported_name":"JOHNSON JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-23T20:35:45.000Z","date":"2026-06-19","kind":"exercise","planned":false,"acquired":true,"shares":14150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of restricted stock units that vested June 19, 2026."}],"balance_after":14150,"source":{"system":"sec-edgar","filing":"0001410781-26-000006","document":"wk-form4_1782246942.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000141078126000006/wk-form4_1782246942.xml","form_type":"4"}},{"id":729759,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-23T20:35:16.000Z","date":"2026-06-19","kind":"exercise","planned":false,"acquired":true,"shares":14150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on June 19, 2026, the one-year anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on June 19, 2026, the one-year anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":14150},"source":{"system":"sec-edgar","filing":"0000805928-26-000076","document":"wk-form4_1782246910.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000076/wk-form4_1782246910.xml","form_type":"4"}},{"id":729758,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35288,"kind":"person","name":"Burke William P. Mr.","position":1,"cik":"0001682069","reported_name":"Burke William P. Mr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-23T20:35:16.000Z","date":"2026-06-19","kind":"exercise","planned":false,"acquired":true,"shares":14150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of restricted stock units that vested June 19, 2026."}],"balance_after":14250,"source":{"system":"sec-edgar","filing":"0000805928-26-000076","document":"wk-form4_1782246910.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000076/wk-form4_1782246910.xml","form_type":"4"}},{"id":783522,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to purchase)","published_at":"2026-05-12T20:06:30.000Z","date":"2026-05-08","kind":"exercise","planned":false,"acquired":false,"shares":1647,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All shares of Axogen, Inc. common stock underlying the board of director's stock option were fully vested on May 31, 2018."}],"balance_after":13353,"derivative":{"exercise_price":14.85,"expiration_date":"2027-06-01","underlying":"Common Stock","underlying_shares":1647},"source":{"system":"sec-edgar","filing":"0001400568-26-000009","document":"wk-form4_1778616387.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/805928/000140056826000009/wk-form4_1778616387.xml","form_type":"4"}},{"id":783521,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-12T20:06:30.000Z","date":"2026-05-08","kind":"sale","planned":false,"acquired":false,"shares":1647,"price":42.6,"value":70162.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $42.50 to $42.62 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":93826,"source":{"system":"sec-edgar","filing":"0001400568-26-000009","document":"wk-form4_1778616387.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000140056826000009/wk-form4_1778616387.xml","form_type":"4"}},{"id":783520,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-12T20:06:30.000Z","date":"2026-05-08","kind":"exercise","planned":false,"acquired":true,"shares":1647,"price":14.85,"value":24457.95,"ownership":{"direct":true},"balance_after":95473,"source":{"system":"sec-edgar","filing":"0001400568-26-000009","document":"wk-form4_1778616387.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000140056826000009/wk-form4_1778616387.xml","form_type":"4"}},{"id":787830,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":13228,"kind":"person","name":"JOHNSON JOHN","position":1,"cik":"0001410781","reported_name":"JOHNSON JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to purchase)","published_at":"2026-05-08T20:07:59.000Z","date":"2026-05-07","kind":"exercise","planned":false,"acquired":false,"shares":11050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All shares of Axogen, Inc. common stock underlying the board of director stock option were fully vested on June 6, 2025."}],"balance_after":0,"derivative":{"exercise_price":7.04,"expiration_date":"2034-06-06","underlying":"Common Stock","underlying_shares":11050},"source":{"system":"sec-edgar","filing":"0001410781-26-000002","document":"wk-form4_1778270876.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/805928/000141078126000002/wk-form4_1778270876.xml","form_type":"4"}},{"id":787829,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":13228,"kind":"person","name":"JOHNSON JOHN","position":1,"cik":"0001410781","reported_name":"JOHNSON JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-08T20:07:59.000Z","date":"2026-05-07","kind":"sale","planned":false,"acquired":false,"shares":11050,"price":43.255,"value":477967.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $43.25 to $43.35 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001410781-26-000002","document":"wk-form4_1778270876.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000141078126000002/wk-form4_1778270876.xml","form_type":"4"}},{"id":787828,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":13228,"kind":"person","name":"JOHNSON JOHN","position":1,"cik":"0001410781","reported_name":"JOHNSON JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-08T20:07:59.000Z","date":"2026-05-07","kind":"exercise","planned":false,"acquired":true,"shares":11050,"price":7.04,"value":77792.0,"ownership":{"direct":true},"balance_after":11050,"source":{"system":"sec-edgar","filing":"0001410781-26-000002","document":"wk-form4_1778270876.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000141078126000002/wk-form4_1778270876.xml","form_type":"4"}},{"id":787827,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24844,"kind":"person","name":"Weiler Kathy Johnson","position":1,"cik":"0001979466","reported_name":"Weiler Kathy Johnson","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to purchase)","published_at":"2026-05-08T20:07:38.000Z","date":"2026-05-07","kind":"exercise","planned":false,"acquired":false,"shares":16344,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option grant for joining the Issuer's Board of Directors. Options vest in three equal annual installments on the annual anniversary of the grant date with the first vesting date occurring on December 20, 2024."}],"balance_after":27307,"derivative":{"exercise_price":6.95,"expiration_date":"2033-12-20","underlying":"Common Stock","underlying_shares":16344},"source":{"system":"sec-edgar","filing":"0000805928-26-000069","document":"wk-form4_1778270855.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000069/wk-form4_1778270855.xml","form_type":"4"}},{"id":787826,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24844,"kind":"person","name":"Weiler Kathy Johnson","position":1,"cik":"0001979466","reported_name":"Weiler Kathy Johnson","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-08T20:07:38.000Z","date":"2026-05-07","kind":"sale","planned":false,"acquired":false,"shares":16344,"price":44.091,"value":720623.304,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $44.04 to $44.26 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000805928-26-000069","document":"wk-form4_1778270855.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000069/wk-form4_1778270855.xml","form_type":"4"}},{"id":787825,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24844,"kind":"person","name":"Weiler Kathy Johnson","position":1,"cik":"0001979466","reported_name":"Weiler Kathy Johnson","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-08T20:07:38.000Z","date":"2026-05-07","kind":"exercise","planned":false,"acquired":true,"shares":16344,"price":6.95,"value":113590.8,"ownership":{"direct":true},"balance_after":16344,"source":{"system":"sec-edgar","filing":"0000805928-26-000069","document":"wk-form4_1778270855.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000069/wk-form4_1778270855.xml","form_type":"4"}},{"id":787824,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":48939,"kind":"person","name":"Kemp Jens","position":1,"cik":"0002007485","reported_name":"Kemp Jens","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Marketing Officer"}}],"security":"Common Stock","published_at":"2026-05-08T20:07:03.000Z","date":"2026-05-07","kind":"sale","planned":false,"acquired":false,"shares":4000,"price":43.4403,"value":173761.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $43.44 to $43.45 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":72451,"source":{"system":"sec-edgar","filing":"0000805928-26-000068","document":"wk-form4_1778270821.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000068/wk-form4_1778270821.xml","form_type":"4"}},{"id":787823,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":48938,"kind":"person","name":"Hartley Lindsey Marie","position":1,"cik":"0002068693","reported_name":"Hartley Lindsey Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Employee Stock Option (right to purchase)","published_at":"2026-05-08T20:06:46.000Z","date":"2026-05-07","kind":"exercise","planned":false,"acquired":false,"shares":2963,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All shares of Axogen, Inc. common stock underlying the employee stock option will be fully vested on March 16, 2027 (4 years from the option grant date) based upon a vesting schedule whereby 50% of the aggregate shares vested on March 16, 2025 (24 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter."}],"balance_after":0,"derivative":{"exercise_price":8.27,"expiration_date":"2033-03-16","underlying":"Common Stock","underlying_shares":2963},"source":{"system":"sec-edgar","filing":"0000805928-26-000067","document":"wk-form4_1778270803.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000067/wk-form4_1778270803.xml","form_type":"4"}},{"id":787822,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":48938,"kind":"person","name":"Hartley Lindsey Marie","position":1,"cik":"0002068693","reported_name":"Hartley Lindsey Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Employee Stock Option (right to purchase)","published_at":"2026-05-08T20:06:46.000Z","date":"2026-05-07","kind":"exercise","planned":false,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All shares of Axogen, Inc. common stock underlying the employee stock option were fully vested on March 16, 2026."}],"balance_after":0,"derivative":{"exercise_price":8.2,"expiration_date":"2032-03-16","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0000805928-26-000067","document":"wk-form4_1778270803.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000067/wk-form4_1778270803.xml","form_type":"4"}},{"id":787821,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":48938,"kind":"person","name":"Hartley Lindsey Marie","position":1,"cik":"0002068693","reported_name":"Hartley Lindsey Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-05-08T20:06:46.000Z","date":"2026-05-07","kind":"sale","planned":false,"acquired":false,"shares":573,"price":43.67,"value":25022.91,"ownership":{"direct":true},"balance_after":65146,"source":{"system":"sec-edgar","filing":"0000805928-26-000067","document":"wk-form4_1778270803.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000067/wk-form4_1778270803.xml","form_type":"4"}},{"id":787820,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":48938,"kind":"person","name":"Hartley Lindsey Marie","position":1,"cik":"0002068693","reported_name":"Hartley Lindsey Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-05-08T20:06:46.000Z","date":"2026-05-07","kind":"exercise","planned":false,"acquired":true,"shares":2963,"price":8.27,"value":24504.01,"ownership":{"direct":true},"balance_after":65719,"source":{"system":"sec-edgar","filing":"0000805928-26-000067","document":"wk-form4_1778270803.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000067/wk-form4_1778270803.xml","form_type":"4"}},{"id":787819,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":48938,"kind":"person","name":"Hartley Lindsey Marie","position":1,"cik":"0002068693","reported_name":"Hartley Lindsey Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-05-08T20:06:46.000Z","date":"2026-05-07","kind":"sale","planned":false,"acquired":false,"shares":478,"price":43.67,"value":20874.26,"ownership":{"direct":true},"balance_after":62756,"source":{"system":"sec-edgar","filing":"0000805928-26-000067","document":"wk-form4_1778270803.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000067/wk-form4_1778270803.xml","form_type":"4"}},{"id":787818,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":48938,"kind":"person","name":"Hartley Lindsey Marie","position":1,"cik":"0002068693","reported_name":"Hartley Lindsey Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-05-08T20:06:46.000Z","date":"2026-05-07","kind":"exercise","planned":false,"acquired":true,"shares":2500,"price":8.2,"value":20500.0,"ownership":{"direct":true},"balance_after":63234,"source":{"system":"sec-edgar","filing":"0000805928-26-000067","document":"wk-form4_1778270803.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000067/wk-form4_1778270803.xml","form_type":"4"}},{"id":787817,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":48937,"kind":"person","name":"Quackenbush Doris","position":1,"cik":"0002133244","reported_name":"Quackenbush Doris","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sales VP"}}],"security":"Common Stock","published_at":"2026-05-08T20:06:27.000Z","date":"2026-05-07","kind":"sale","planned":false,"acquired":false,"shares":3878,"price":43.507,"value":168720.146,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $43.50 to $44.00 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":92416,"source":{"system":"sec-edgar","filing":"0000805928-26-000066","document":"wk-form4_1778270784.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000066/wk-form4_1778270784.xml","form_type":"4"}},{"id":836089,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":59636,"kind":"person","name":"DeVinney Erick Wayne","position":1,"cik":"0001595972","reported_name":"DeVinney Erick Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-18T20:11:17.000Z","date":"2026-03-16","kind":"exercise","planned":false,"acquired":true,"shares":11575,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2027 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vested on March 16, 2025 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares are delivered to the reporting person upon the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2027 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vested on March 16, 2025 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares are delivered to the reporting person upon the vesting date."}],"balance_after":11575,"derivative":{"underlying":"Common Stock","underlying_shares":11575},"source":{"system":"sec-edgar","filing":"0000805928-26-000048","document":"wk-form4_1773864674.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000048/wk-form4_1773864674.xml","form_type":"4"}},{"id":836088,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":59636,"kind":"person","name":"DeVinney Erick Wayne","position":1,"cik":"0001595972","reported_name":"DeVinney Erick Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-18T20:11:17.000Z","date":"2026-03-16","kind":"exercise","planned":false,"acquired":true,"shares":6363,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"All shares of Axogen Inc. common stock underlying the restricted stock units are fully vested on March 16, 2026 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vested on March 16, 2024 (24 months from the grant date) and an additional 25% of the aggregate shares vested each 12 months thereafter. Vested shares are delivered to the reporting person upon the vesting dates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"All shares of Axogen Inc. common stock underlying the restricted stock units are fully vested on March 16, 2026 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vested on March 16, 2024 (24 months from the grant date) and an additional 25% of the aggregate shares vested each 12 months thereafter. Vested shares are delivered to the reporting person upon the vesting dates."}],"balance_after":6363,"derivative":{"underlying":"Common Stock","underlying_shares":6363},"source":{"system":"sec-edgar","filing":"0000805928-26-000048","document":"wk-form4_1773864674.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000048/wk-form4_1773864674.xml","form_type":"4"}},{"id":836087,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":59636,"kind":"person","name":"DeVinney Erick Wayne","position":1,"cik":"0001595972","reported_name":"DeVinney Erick Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2026-03-18T20:11:17.000Z","date":"2026-03-16","kind":"sale","planned":false,"acquired":false,"shares":5221,"price":32.84,"value":171457.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This represents the number of shares of Common Stock that have been withheld by the issuer to satisfy tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent an open market sale."}],"balance_after":262781,"source":{"system":"sec-edgar","filing":"0000805928-26-000048","document":"wk-form4_1773864674.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000048/wk-form4_1773864674.xml","form_type":"4"}},{"id":836086,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":59636,"kind":"person","name":"DeVinney Erick Wayne","position":1,"cik":"0001595972","reported_name":"DeVinney Erick Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2026-03-18T20:11:17.000Z","date":"2026-03-16","kind":"exercise","planned":false,"acquired":true,"shares":11575,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of restricted stock units (\"RSUs\") that vested on March 16, 2026."}],"balance_after":268002,"source":{"system":"sec-edgar","filing":"0000805928-26-000048","document":"wk-form4_1773864674.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000048/wk-form4_1773864674.xml","form_type":"4"}},{"id":836085,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":59636,"kind":"person","name":"DeVinney Erick Wayne","position":1,"cik":"0001595972","reported_name":"DeVinney Erick Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2026-03-18T20:11:17.000Z","date":"2026-03-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":2870,"price":32.84,"value":94250.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This represents the number of shares of Common Stock that have been withheld by the issuer to satisfy tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent an open market sale."}],"balance_after":256427,"source":{"system":"sec-edgar","filing":"0000805928-26-000048","document":"wk-form4_1773864674.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000048/wk-form4_1773864674.xml","form_type":"4"}},{"id":836084,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":59636,"kind":"person","name":"DeVinney Erick Wayne","position":1,"cik":"0001595972","reported_name":"DeVinney Erick Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2026-03-18T20:11:17.000Z","date":"2026-03-16","kind":"exercise","planned":false,"acquired":true,"shares":6363,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of restricted stock units (\"RSUs\") that vested on March 16, 2026."}],"balance_after":259297,"source":{"system":"sec-edgar","filing":"0000805928-26-000048","document":"wk-form4_1773864674.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000048/wk-form4_1773864674.xml","form_type":"4"}},{"id":836083,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":48938,"kind":"person","name":"Hartley Lindsey Marie","position":1,"cik":"0002068693","reported_name":"Hartley Lindsey Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Units","published_at":"2026-03-18T20:10:01.000Z","date":"2026-03-16","kind":"exercise","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"All shares of Axogen Inc. common stock underlying the restricted stock units are fully vested on March 16, 2026 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vested on March 16, 2024 (24 months from the grant date) and an additional 25% of the aggregate shares vested each 12 months thereafter. Vested shares are delivered to the reporting person upon the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"All shares of Axogen Inc. common stock underlying the restricted stock units are fully vested on March 16, 2026 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vested on March 16, 2024 (24 months from the grant date) and an additional 25% of the aggregate shares vested each 12 months thereafter. Vested shares are delivered to the reporting person upon the vesting date."}],"balance_after":5000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000805928-26-000047","document":"wk-form4_1773864598.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000047/wk-form4_1773864598.xml","form_type":"4"}},{"id":836082,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":48938,"kind":"person","name":"Hartley Lindsey Marie","position":1,"cik":"0002068693","reported_name":"Hartley Lindsey Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Units","published_at":"2026-03-18T20:10:01.000Z","date":"2026-03-16","kind":"exercise","planned":false,"acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2027 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vested on March 16, 2025 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares are delivered to the reporting person upon the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2027 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vested on March 16, 2025 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares are delivered to the reporting person upon the vesting date."}],"balance_after":4000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0000805928-26-000047","document":"wk-form4_1773864598.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000047/wk-form4_1773864598.xml","form_type":"4"}},{"id":836081,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":48938,"kind":"person","name":"Hartley Lindsey Marie","position":1,"cik":"0002068693","reported_name":"Hartley Lindsey Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-03-18T20:10:01.000Z","date":"2026-03-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":1968,"price":32.84,"value":64629.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This represents the number of shares of Common Stock that have been withheld by the issuer to satisfy tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent an open market sale."}],"balance_after":60734,"source":{"system":"sec-edgar","filing":"0000805928-26-000047","document":"wk-form4_1773864598.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000047/wk-form4_1773864598.xml","form_type":"4"}},{"id":836080,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":48938,"kind":"person","name":"Hartley Lindsey Marie","position":1,"cik":"0002068693","reported_name":"Hartley Lindsey Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-03-18T20:10:01.000Z","date":"2026-03-16","kind":"exercise","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of restricted stock units (\"RSUs\") that vested on March 16, 2026."}],"balance_after":62702,"source":{"system":"sec-edgar","filing":"0000805928-26-000047","document":"wk-form4_1773864598.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000047/wk-form4_1773864598.xml","form_type":"4"}},{"id":836079,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":48938,"kind":"person","name":"Hartley Lindsey Marie","position":1,"cik":"0002068693","reported_name":"Hartley Lindsey Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-03-18T20:10:01.000Z","date":"2026-03-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":1574,"price":32.84,"value":51690.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This represents the number of shares of Common Stock that have been withheld by the issuer to satisfy tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent an open market sale."}],"balance_after":57702,"source":{"system":"sec-edgar","filing":"0000805928-26-000047","document":"wk-form4_1773864598.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000047/wk-form4_1773864598.xml","form_type":"4"}},{"id":836078,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":48938,"kind":"person","name":"Hartley Lindsey Marie","position":1,"cik":"0002068693","reported_name":"Hartley Lindsey Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-03-18T20:10:01.000Z","date":"2026-03-16","kind":"exercise","planned":false,"acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of restricted stock units (\"RSUs\") that vested on March 16, 2026."}],"balance_after":59276,"source":{"system":"sec-edgar","filing":"0000805928-26-000047","document":"wk-form4_1773864598.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000047/wk-form4_1773864598.xml","form_type":"4"}},{"id":875719,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":48939,"kind":"person","name":"Kemp Jens","position":1,"cik":"0002007485","reported_name":"Kemp Jens","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Marketing Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-02T23:16:56.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on February 26, 2030 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on February 26, 2028 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on February 26, 2030 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on February 26, 2028 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date."}],"balance_after":23000,"derivative":{"underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0000805928-26-000044","document":"wk-form4_1772493414.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000044/wk-form4_1772493414.xml","form_type":"4"}},{"id":875718,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":48939,"kind":"person","name":"Kemp Jens","position":1,"cik":"0002007485","reported_name":"Kemp Jens","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Marketing Officer"}}],"security":"Common Stock","published_at":"2026-03-02T23:16:56.000Z","date":"2026-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":2952,"price":30.65,"value":90478.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"No shares were sold by the reporting person. The transaction disclosed represents shares of the issuer's Common Stock withheld by the issuer in payment of the withholding tax liability incurred upon the vesting of restricted stock units (\"RSUs\")."}],"balance_after":76451,"source":{"system":"sec-edgar","filing":"0000805928-26-000044","document":"wk-form4_1772493414.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000044/wk-form4_1772493414.xml","form_type":"4"}},{"id":875717,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":48939,"kind":"person","name":"Kemp Jens","position":1,"cik":"0002007485","reported_name":"Kemp Jens","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Marketing Officer"}}],"security":"Common Stock","published_at":"2026-03-02T23:16:56.000Z","date":"2026-02-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":15414,"price":31.9,"value":491706.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"No shares were sold by the reporting person. The transaction disclosed represents shares of the issuer's  Common Stock withheld by the issuer in payment of the withholding tax liability incurred upon the vesting of performance stock units (\"PSUs\")."}],"balance_after":79403,"source":{"system":"sec-edgar","filing":"0000805928-26-000044","document":"wk-form4_1772493414.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000044/wk-form4_1772493414.xml","form_type":"4"}},{"id":875716,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":48939,"kind":"person","name":"Kemp Jens","position":1,"cik":"0002007485","reported_name":"Kemp Jens","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Marketing Officer"}}],"security":"Common Stock","published_at":"2026-03-02T23:16:56.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":50670,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of shares that became vested as of February 26, 2026, upon the attainment and certification of certain performance criteria."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The previous Form 4 filed by the Reporting Person overstated the number of shares beneficially owned by the Reporting Person by 4,003 shares of Common Stock. The amount reported herein has been corrected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 2,120 shares acquired under the Axogen Employee Stock Purchase Plan on December 31, 2025."}],"balance_after":94817,"source":{"system":"sec-edgar","filing":"0000805928-26-000044","document":"wk-form4_1772493414.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000044/wk-form4_1772493414.xml","form_type":"4"}},{"id":875715,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":59636,"kind":"person","name":"DeVinney Erick Wayne","position":1,"cik":"0001595972","reported_name":"DeVinney Erick Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-02T23:16:14.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on February 26, 2030 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on February 26, 2028 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on February 26, 2030 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on February 26, 2028 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date."}],"balance_after":23000,"derivative":{"underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0000805928-26-000043","document":"wk-form4_1772493371.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000043/wk-form4_1772493371.xml","form_type":"4"}},{"id":875714,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":59636,"kind":"person","name":"DeVinney Erick Wayne","position":1,"cik":"0001595972","reported_name":"DeVinney Erick Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2026-03-02T23:16:14.000Z","date":"2026-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":11276,"price":30.65,"value":345609.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"No shares were sold by the reporting person. The transaction disclosed represents shares of the issuer's Common Stock withheld by the issuer in payment of the withholding tax liability incurred upon the vesting of restricted stock units (\"RSUs\")."}],"balance_after":252934,"source":{"system":"sec-edgar","filing":"0000805928-26-000043","document":"wk-form4_1772493371.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000043/wk-form4_1772493371.xml","form_type":"4"}},{"id":875713,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":59636,"kind":"person","name":"DeVinney Erick Wayne","position":1,"cik":"0001595972","reported_name":"DeVinney Erick Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2026-03-02T23:16:14.000Z","date":"2026-02-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":10702,"price":31.9,"value":341393.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"No shares were sold by the reporting person. The transaction disclosed represents shares of the issuer's Common Stock withheld by the issuer in payment of the withholding tax liability incurred upon the vesting of performance stock units (\"PSUs\")."}],"balance_after":264210,"source":{"system":"sec-edgar","filing":"0000805928-26-000043","document":"wk-form4_1772493371.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000043/wk-form4_1772493371.xml","form_type":"4"}},{"id":875712,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":59636,"kind":"person","name":"DeVinney Erick Wayne","position":1,"cik":"0001595972","reported_name":"DeVinney Erick Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2026-03-02T23:16:14.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":33780,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of shares that became vested as of February 26, 2026, upon the attainment and certification of certain performance criteria."}],"balance_after":274912,"source":{"system":"sec-edgar","filing":"0000805928-26-000043","document":"wk-form4_1772493371.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000043/wk-form4_1772493371.xml","form_type":"4"}},{"id":875711,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24363,"kind":"person","name":"Began Marc A","position":1,"cik":"0001821352","reported_name":"Began Marc A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2026-03-02T23:15:48.000Z","date":"2026-03-01","kind":"exercise","planned":false,"acquired":true,"shares":11250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each RSU represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"All shares of Axogen, Inc. common stock underlying the RSUs will be fully vested on March 1, 2027 based on a vesting schedule whereby 50% of the aggregate shares vest on March 1, 2025, and an additional 25% of the aggregate shares vest each twelve months thereafter. Vested shares will be delivered to the Reporting Person upon the vesting date. The RSUs were granted pursuant to an inducement award agreement outside of the Issuer's Amended and Restated 2019 Long-Term Incentive Plan as a material inducement to the Reporting Person's acceptance of employment with the Issuer in accordance with NASDAQ Listing Rule 5635(c)(4)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"All shares of Axogen, Inc. common stock underlying the RSUs will be fully vested on March 1, 2027 based on a vesting schedule whereby 50% of the aggregate shares vest on March 1, 2025, and an additional 25% of the aggregate shares vest each twelve months thereafter. Vested shares will be delivered to the Reporting Person upon the vesting date. The RSUs were granted pursuant to an inducement award agreement outside of the Issuer's Amended and Restated 2019 Long-Term Incentive Plan as a material inducement to the Reporting Person's acceptance of employment with the Issuer in accordance with NASDAQ Listing Rule 5635(c)(4)."}],"balance_after":11250,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":11250},"source":{"system":"sec-edgar","filing":"0000805928-26-000042","document":"wk-form4_1772493346.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000042/wk-form4_1772493346.xml","form_type":"4"}},{"id":875710,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24363,"kind":"person","name":"Began Marc A","position":1,"cik":"0001821352","reported_name":"Began Marc A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2026-03-02T23:15:48.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each RSU represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"All shares of Axogen Inc. common stock underlying the RSUs will be fully vested on February 26, 2030 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on February 26, 2028 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"All shares of Axogen Inc. common stock underlying the RSUs will be fully vested on February 26, 2030 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on February 26, 2028 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date."}],"balance_after":23000,"derivative":{"underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0000805928-26-000042","document":"wk-form4_1772493346.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000042/wk-form4_1772493346.xml","form_type":"4"}},{"id":875709,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24363,"kind":"person","name":"Began Marc A","position":1,"cik":"0001821352","reported_name":"Began Marc A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock","published_at":"2026-03-02T23:15:48.000Z","date":"2026-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":4427,"price":30.65,"value":135687.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"No shares were sold by the reporting person. The transaction disclosed represents shares of the issuer's Common Stock withheld by the issuer in payment of the withholding tax liability incurred upon the vesting of RSUs."}],"balance_after":50135,"source":{"system":"sec-edgar","filing":"0000805928-26-000042","document":"wk-form4_1772493346.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000042/wk-form4_1772493346.xml","form_type":"4"}},{"id":875708,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24363,"kind":"person","name":"Began Marc A","position":1,"cik":"0001821352","reported_name":"Began Marc A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock","published_at":"2026-03-02T23:15:48.000Z","date":"2026-03-01","kind":"exercise","planned":false,"acquired":true,"shares":11250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This reflects the number of restricted stock units (\"RSUs\")  that vested on March 1, 2026."}],"balance_after":54562,"source":{"system":"sec-edgar","filing":"0000805928-26-000042","document":"wk-form4_1772493346.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000042/wk-form4_1772493346.xml","form_type":"4"}},{"id":875707,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24363,"kind":"person","name":"Began Marc A","position":1,"cik":"0001821352","reported_name":"Began Marc A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock","published_at":"2026-03-02T23:15:48.000Z","date":"2026-02-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":8753,"price":31.9,"value":279220.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"No shares were sold by the reporting person. The transaction disclosed represents shares of the issuer's  Common Stock withheld by the issuer in payment of the withholding tax liability incurred upon the vesting of performance stock units (\"PSUs\")."}],"balance_after":43312,"source":{"system":"sec-edgar","filing":"0000805928-26-000042","document":"wk-form4_1772493346.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000042/wk-form4_1772493346.xml","form_type":"4"}},{"id":875706,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24363,"kind":"person","name":"Began Marc A","position":1,"cik":"0001821352","reported_name":"Began Marc A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock","published_at":"2026-03-02T23:15:48.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":33780,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of shares that became vested as of February 26, 2026, upon the attainment and certification of certain performance criteria."}],"balance_after":52065,"source":{"system":"sec-edgar","filing":"0000805928-26-000042","document":"wk-form4_1772493346.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000042/wk-form4_1772493346.xml","form_type":"4"}},{"id":878660,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":48938,"kind":"person","name":"Hartley Lindsey Marie","position":1,"cik":"0002068693","reported_name":"Hartley Lindsey Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Units","published_at":"2026-02-27T21:21:45.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on February 26, 2030 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on February 26, 2028 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on February 26, 2030 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on February 26, 2028 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date."}],"balance_after":23000,"derivative":{"underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0000805928-26-000038","document":"wk-form4_1772227303.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000038/wk-form4_1772227303.xml","form_type":"4"}},{"id":878659,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":48938,"kind":"person","name":"Hartley Lindsey Marie","position":1,"cik":"0002068693","reported_name":"Hartley Lindsey Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-02-27T21:21:45.000Z","date":"2026-02-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":6630,"price":31.9,"value":211497.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This represents the number of shares of Common Stock that have been withheld by the issuer to satisfy tax withholding and remittance obligations in connection with the net settlement of the PSUs and does not represent an open market sale."}],"balance_after":55276,"source":{"system":"sec-edgar","filing":"0000805928-26-000038","document":"wk-form4_1772227303.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000038/wk-form4_1772227303.xml","form_type":"4"}},{"id":878658,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":48938,"kind":"person","name":"Hartley Lindsey Marie","position":1,"cik":"0002068693","reported_name":"Hartley Lindsey Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-02-27T21:21:45.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":17453,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of shares that became vested as of February 26, 2026, upon the attainment and certification of certain performance criteria."}],"balance_after":61906,"source":{"system":"sec-edgar","filing":"0000805928-26-000038","document":"wk-form4_1772227303.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000038/wk-form4_1772227303.xml","form_type":"4"}},{"id":878654,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":15392,"kind":"person","name":"DALE MICHAEL D","position":1,"cik":"0001172346","reported_name":"DALE MICHAEL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-27T21:20:02.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":98000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on February 26, 2030 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on February 26, 2028 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on February 26, 2030 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on February 26, 2028 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date."}],"balance_after":98000,"derivative":{"underlying":"Common Stock","underlying_shares":98000},"source":{"system":"sec-edgar","filing":"0000805928-26-000036","document":"wk-form4_1772227199.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000036/wk-form4_1772227199.xml","form_type":"4"}},{"id":886616,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":48938,"kind":"person","name":"Hartley Lindsey Marie","position":1,"cik":"0002068693","reported_name":"Hartley Lindsey Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Units","published_at":"2026-02-24T21:26:33.000Z","date":"2026-02-22","kind":"grant","planned":false,"acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on February 22, 2028 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on February 22, 2026 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on February 22, 2028 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on February 22, 2026 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date."}],"balance_after":17500,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0000805928-26-000032","document":"wk-form4_1771968389.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000032/wk-form4_1771968389.xml","form_type":"4"}},{"id":886615,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":48938,"kind":"person","name":"Hartley Lindsey Marie","position":1,"cik":"0002068693","reported_name":"Hartley Lindsey Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-02-24T21:26:33.000Z","date":"2026-02-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":6704,"price":35.38,"value":237187.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"No shares were sold by the reporting person. The transaction disclosed represents shares of the issuer's Class A Common Stock withheld by the issuer in payment of the withholding tax liability incurred upon the vesting of restricted stock units (\"RSUs\")."}],"balance_after":44453,"source":{"system":"sec-edgar","filing":"0000805928-26-000032","document":"wk-form4_1771968389.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000032/wk-form4_1771968389.xml","form_type":"4"}},{"id":886614,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":48938,"kind":"person","name":"Hartley Lindsey Marie","position":1,"cik":"0002068693","reported_name":"Hartley Lindsey Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-02-24T21:26:33.000Z","date":"2026-02-22","kind":"grant","planned":false,"acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 2,281 shares acquired under the Axogen Employee Stock Purchase Plan on December 31, 2025."}],"balance_after":51157,"source":{"system":"sec-edgar","filing":"0000805928-26-000032","document":"wk-form4_1771968389.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000032/wk-form4_1771968389.xml","form_type":"4"}},{"id":966164,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2025-12-17T21:25:23.000Z","date":"2025-12-16","kind":"exercise","planned":false,"acquired":false,"shares":18248,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Board of Directors' non-qualified stock option grant that vested in full June 6, 2025."}],"balance_after":0,"derivative":{"exercise_price":7.04,"expiration_date":"2034-06-06","underlying":"Common Stock","underlying_shares":18248},"source":{"system":"sec-edgar","filing":"0001400568-25-000005","document":"wk-form4_1766006718.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/805928/000140056825000005/wk-form4_1766006718.xml","form_type":"4"}},{"id":966163,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2025-12-17T21:25:23.000Z","date":"2025-12-16","kind":"exercise","planned":false,"acquired":false,"shares":20436,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Board of Directors' non-qualified stock option grant that vested in full September 1, 2024."}],"balance_after":0,"derivative":{"exercise_price":6.3,"expiration_date":"2033-09-01","underlying":"Common Stock","underlying_shares":20436},"source":{"system":"sec-edgar","filing":"0001400568-25-000005","document":"wk-form4_1766006718.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/805928/000140056825000005/wk-form4_1766006718.xml","form_type":"4"}},{"id":966162,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2025-12-17T21:25:23.000Z","date":"2025-12-16","kind":"exercise","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Board of Directors' non-qualified stock option grant that vested in full May 26, 2017."}],"balance_after":0,"derivative":{"exercise_price":8.95,"expiration_date":"2026-12-29","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001400568-25-000005","document":"wk-form4_1766006718.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/805928/000140056825000005/wk-form4_1766006718.xml","form_type":"4"}},{"id":966161,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-17T21:25:23.000Z","date":"2025-12-16","kind":"sale","planned":false,"acquired":false,"shares":18248,"price":29.312,"value":534885.376,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $28.99 to $29.63 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":93826,"source":{"system":"sec-edgar","filing":"0001400568-25-000005","document":"wk-form4_1766006718.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/805928/000140056825000005/wk-form4_1766006718.xml","form_type":"4"}},{"id":966160,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-17T21:25:23.000Z","date":"2025-12-16","kind":"sale","planned":false,"acquired":false,"shares":20436,"price":29.312,"value":599020.032,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $28.99 to $29.63 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":112074,"source":{"system":"sec-edgar","filing":"0001400568-25-000005","document":"wk-form4_1766006718.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/805928/000140056825000005/wk-form4_1766006718.xml","form_type":"4"}},{"id":966159,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-17T21:25:23.000Z","date":"2025-12-16","kind":"sale","planned":false,"acquired":false,"shares":5000,"price":29.312,"value":146560.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $28.99 to $29.63 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":132510,"source":{"system":"sec-edgar","filing":"0001400568-25-000005","document":"wk-form4_1766006718.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/805928/000140056825000005/wk-form4_1766006718.xml","form_type":"4"}},{"id":966158,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-17T21:25:23.000Z","date":"2025-12-16","kind":"exercise","planned":false,"acquired":true,"shares":18248,"price":7.04,"value":128465.92,"ownership":{"direct":true},"balance_after":137510,"source":{"system":"sec-edgar","filing":"0001400568-25-000005","document":"wk-form4_1766006718.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/805928/000140056825000005/wk-form4_1766006718.xml","form_type":"4"}},{"id":966157,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-17T21:25:23.000Z","date":"2025-12-16","kind":"exercise","planned":false,"acquired":true,"shares":20436,"price":6.3,"value":128746.8,"ownership":{"direct":true},"balance_after":119262,"source":{"system":"sec-edgar","filing":"0001400568-25-000005","document":"wk-form4_1766006718.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000140056825000005/wk-form4_1766006718.xml","form_type":"4"}},{"id":966156,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24362,"kind":"person","name":"Wendell Amy McBride","position":1,"cik":"0001400568","reported_name":"Wendell Amy McBride","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-17T21:25:23.000Z","date":"2025-12-16","kind":"exercise","planned":false,"acquired":true,"shares":5000,"price":8.95,"value":44750.0,"ownership":{"direct":true},"balance_after":98826,"source":{"system":"sec-edgar","filing":"0001400568-25-000005","document":"wk-form4_1766006718.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000140056825000005/wk-form4_1766006718.xml","form_type":"4"}},{"id":966155,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24844,"kind":"person","name":"Weiler Kathy Johnson","position":1,"cik":"0001979466","reported_name":"Weiler Kathy Johnson","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to purchase)","published_at":"2025-12-17T21:25:04.000Z","date":"2025-12-16","kind":"exercise","planned":false,"acquired":false,"shares":21825,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option grant for joining the Issuer's Board of Directors. Options vest in three equal annual installments on the annual anniversary of the grant date with the first vesting date occurring on December 20, 2024."}],"balance_after":43651,"derivative":{"exercise_price":6.95,"expiration_date":"2033-12-20","underlying":"Common Stock","underlying_shares":21825},"source":{"system":"sec-edgar","filing":"0000805928-25-000177","document":"wk-form4_1766006701.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000177/wk-form4_1766006701.xml","form_type":"4"}},{"id":966154,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24844,"kind":"person","name":"Weiler Kathy Johnson","position":1,"cik":"0001979466","reported_name":"Weiler Kathy Johnson","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to purchase)","published_at":"2025-12-17T21:25:04.000Z","date":"2025-12-16","kind":"exercise","planned":false,"acquired":false,"shares":18248,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Non-qualified stock option portion of the annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The grant fully vested on June 6, 2025, the one-year anniversary of the date of the grant."}],"balance_after":0,"derivative":{"exercise_price":7.04,"expiration_date":"2034-06-06","underlying":"Common Stock","underlying_shares":18248},"source":{"system":"sec-edgar","filing":"0000805928-25-000177","document":"wk-form4_1766006701.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000177/wk-form4_1766006701.xml","form_type":"4"}},{"id":966153,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24844,"kind":"person","name":"Weiler Kathy Johnson","position":1,"cik":"0001979466","reported_name":"Weiler Kathy Johnson","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-17T21:25:04.000Z","date":"2025-12-16","kind":"sale","planned":false,"acquired":false,"shares":6580,"price":29.55,"value":194439.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0000805928-25-000177","document":"wk-form4_1766006701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000177/wk-form4_1766006701.xml","form_type":"4"}},{"id":966152,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24844,"kind":"person","name":"Weiler Kathy Johnson","position":1,"cik":"0001979466","reported_name":"Weiler Kathy Johnson","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-17T21:25:04.000Z","date":"2025-12-16","kind":"sale","planned":false,"acquired":false,"shares":21825,"price":29.547,"value":644863.275,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $29.01 to $30.00 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":6580,"source":{"system":"sec-edgar","filing":"0000805928-25-000177","document":"wk-form4_1766006701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000177/wk-form4_1766006701.xml","form_type":"4"}},{"id":966151,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24844,"kind":"person","name":"Weiler Kathy Johnson","position":1,"cik":"0001979466","reported_name":"Weiler Kathy Johnson","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-17T21:25:04.000Z","date":"2025-12-16","kind":"sale","planned":false,"acquired":false,"shares":18248,"price":29.547,"value":539173.656,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $29.01 to $30.00 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":28405,"source":{"system":"sec-edgar","filing":"0000805928-25-000177","document":"wk-form4_1766006701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000177/wk-form4_1766006701.xml","form_type":"4"}},{"id":966150,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24844,"kind":"person","name":"Weiler Kathy Johnson","position":1,"cik":"0001979466","reported_name":"Weiler Kathy Johnson","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-17T21:25:04.000Z","date":"2025-12-16","kind":"exercise","planned":false,"acquired":true,"shares":21825,"price":6.95,"value":151683.75,"ownership":{"direct":true},"balance_after":46653,"source":{"system":"sec-edgar","filing":"0000805928-25-000177","document":"wk-form4_1766006701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000177/wk-form4_1766006701.xml","form_type":"4"}},{"id":966149,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24844,"kind":"person","name":"Weiler Kathy Johnson","position":1,"cik":"0001979466","reported_name":"Weiler Kathy Johnson","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-17T21:25:04.000Z","date":"2025-12-16","kind":"exercise","planned":false,"acquired":true,"shares":18248,"price":7.04,"value":128465.92,"ownership":{"direct":true},"balance_after":24828,"source":{"system":"sec-edgar","filing":"0000805928-25-000177","document":"wk-form4_1766006701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000177/wk-form4_1766006701.xml","form_type":"4"}},{"id":966148,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":48938,"kind":"person","name":"Hartley Lindsey Marie","position":1,"cik":"0002068693","reported_name":"Hartley Lindsey Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Employee Stock Option (right to purchase)","published_at":"2025-12-17T21:24:49.000Z","date":"2025-12-15","kind":"exercise","planned":false,"acquired":false,"shares":14812,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All shares of Axogen, Inc. common stock underlying the employee stock option will be fully vested on March 16, 2027 (4 years from the option grant date) based upon a vesting schedule whereby 50% of the aggregate shares vested on March 16, 2025 (24 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter."}],"balance_after":0,"derivative":{"exercise_price":8.27,"expiration_date":"2033-03-16","underlying":"Common Stock","underlying_shares":14812},"source":{"system":"sec-edgar","filing":"0000805928-25-000176","document":"wk-form4_1766006686.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000176/wk-form4_1766006686.xml","form_type":"4"}},{"id":966147,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":48938,"kind":"person","name":"Hartley Lindsey Marie","position":1,"cik":"0002068693","reported_name":"Hartley Lindsey Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2025-12-17T21:24:49.000Z","date":"2025-12-15","kind":"sale","planned":false,"acquired":false,"shares":14812,"price":29.8605,"value":442293.726,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $29.875 to $29.860 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":31376,"source":{"system":"sec-edgar","filing":"0000805928-25-000176","document":"wk-form4_1766006686.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000176/wk-form4_1766006686.xml","form_type":"4"}},{"id":966146,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":48938,"kind":"person","name":"Hartley Lindsey Marie","position":1,"cik":"0002068693","reported_name":"Hartley Lindsey Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2025-12-17T21:24:49.000Z","date":"2025-12-15","kind":"exercise","planned":false,"acquired":true,"shares":14812,"price":8.27,"value":122495.24,"ownership":{"direct":true},"balance_after":46188,"source":{"system":"sec-edgar","filing":"0000805928-25-000176","document":"wk-form4_1766006686.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000176/wk-form4_1766006686.xml","form_type":"4"}},{"id":972066,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":15392,"kind":"person","name":"DALE MICHAEL D","position":1,"cik":"0001172346","reported_name":"DALE MICHAEL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-12T21:06:19.000Z","date":"2025-12-10","kind":"sale","planned":false,"acquired":false,"shares":25000,"price":30,"value":750000.0,"ownership":{"direct":true},"balance_after":63537,"source":{"system":"sec-edgar","filing":"0000805928-25-000171","document":"wk-form4_1765573574.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000171/wk-form4_1765573574.xml","form_type":"4"}},{"id":972065,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24363,"kind":"person","name":"Began Marc A","position":1,"cik":"0001821352","reported_name":"Began Marc A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock","published_at":"2025-12-12T21:05:58.000Z","date":"2025-12-11","kind":"sale","planned":false,"acquired":false,"shares":13222,"price":30,"value":396660.0,"ownership":{"direct":true},"balance_after":18285,"source":{"system":"sec-edgar","filing":"0000805928-25-000170","document":"wk-form4_1765573554.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000170/wk-form4_1765573554.xml","form_type":"4"}}],"next_cursor":"2025-12-12T21:05:58.000000Z,972065"}